The U.S. Preventive Services Task Force reports that available tests aren't good enough, and reliable evidence of benefit is lacking.
Sponsoring Organization: U.S. Preventive Services Task Force (USPSTF)Target Audience: Primary care providers
Background
In 2005, the USPSTF recommended against routine serologic screening for genital herpes simplex virus (HSV) infection in asymptomatic adolescents and adults. The prevalence of this very common sexually transmitted infection — an estimated 16% of 14- to 49-year-olds in the U.S. are infected with genital HSV — prompted a new review of evidence on the accuracy, benefits, and harms of serologic screening for genital HSV infection.
Key Points
Reviewing Author
DisclosuresNothing to disclose
DisclosuresNothing to disclose